A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia

✍ Scribed by R. Willemze; N. van der Lely; H. Zwierzina; S. Suciu; G. Solbu; H. Gerhartz; B. Labar; G. Visani; M. E. Peetermans; A. Jacobs; P. Stryckmans; P. Fenaux; H. L. Haak; M. M. Ribeiro; E. Baumelou; M. Baccarani; F. Mandelli; B. Jaksic; A. Louwagie; A. Thyss; M. Hayat; F. de Cataldo; A. C. Stern; R. Zittoun

• Publisher: Springer
• Year: 1992
• Tongue: English
• Weight: 36 KB
• Volume: 64
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/bf01695479